Evidence map›Paper›PMID 41624524›Full record

ArticleMaterials today. Bio2026

Extracellular matrix-mimetic ink for 3D printing and minimally invasive delivery of shape-memory constructs.

Shima Tavakoli, Dimitra Pouloutidou, Oommen P Oommen, Oommen P Varghese

Abstract read
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shima TavakoliTranslational Chemical Biology Group, Science for Life Laboratory, Division of Macromolecular Chemistry, Department of Chemistry- Ångström Laboratory, Uppsala University, Uppsala SE75121, Sweden.
Dimitra PouloutidouTranslational Chemical Biology Group, Science for Life Laboratory, Division of Macromolecular Chemistry, Department of Chemistry- Ångström Laboratory, Uppsala University, Uppsala SE75121, Sweden.
Oommen P OommenSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, CF10 3NB, United Kingdom.
Oommen P VargheseTranslational Chemical Biology Group, Science for Life Laboratory, Division of Macromolecular Chemistry, Department of Chemistry- Ångström Laboratory, Uppsala University, Uppsala SE75121, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct injection of hydrogels loaded with therapeutics holds great promise for tissue regeneration; however, injectable hydrogels typically fill defect spaces without spatiotemporal control, which is critical for regenerating certain tissues. Conversely, 3D printing enables the fabrication of patterned hydrogel constructs but often requires invasive surgical implantation. Here, we present a novel strategy for the non-invasive delivery of 3D-printed constructs. Specifically, we developed gallic acid-modified hyaluronic acid (HA) that was crosslinked for the first time using potassium iodide (KI) as a catalyst, without the need for an initiator or light exposure. This also enabled protein conjugation with gelatin and collagen to obtain an extracellular matrix (ECM)-mimetic ink for 3D printing. We determined the distinct pKa values of the phenolic hydroxy groups of gallol-modified HA, which were utilized to achieve 3D printing at acidic pH, followed by efficient solution-free covalent crosslinking using ammonia gas to ensure complete crosslinking. This approach enabled efficient printing through fine nozzles (G32) and produced robust structures. The printed scaffolds were subsequently loaded into a larger needle and injected, demonstrating shape-memory properties by retaining their geometry post-injection. Furthermore, the scaffolds supported stem cell coating, where the stemness and differentiation of stem cells could be modulated by hydrogel composition and culture conditions, including chondrogenic differentiation towards cartilage-like constructs using TGF-β3. This strategy offers a versatile platform for developing HA-based hydrogels capable of protein conjugation, 3D printing, cell or biomolecule coating, and minimally invasive implantation while maintaining structural fidelity.

Indexed as

3D printingGallic acidHyaluronic acidHydrogelShape-memory

Identifiers

PMID41624524
PMCPMC12859500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.